that trigger apoptosis, peptides 44-49, 59-60, and 65-67, containing amino acids 331-357, 379-390, and 400-408, respectively , and that it also interacts with the RING finger protein TRAF2 (Rothe et al., 1994) leading to NF-B induction thereby confining an important binding region to amino acids . This corresponds (Hsu et al., 1996a; 1996b) . However, TNF-R55-associated proteins involved in initiating the N-SMase signalwell to the boundaries of the previously identified death domain, spanning approximately amino acids 326-413 ing pathway remained elusive.
In the present study, we report the isolation and char- (Tartaglia et al., 1993b) . The N-terminal half of the TNF-R55 cytoplasmic domain in general exhibited less bindacterization of a novel protein, designated FAN (factor associated with N-SMase activation), which associates ing activity that could be localized to three distinct sites (at least 4-fold above background binding) on peptides with the NSD of human TNF-R55. Sequence analysis classifies FAN as a member of the family of WD-repeat [14] [15] [16] [17] 26 , and the NSD-containing peptide 36, containing amino acids 245-268, 281-295, and 307-321, proteins, a growing family of regulatory proteins, many of which are involved in signal transduction. Overexrespectively (Figures 1B and 1C) . Notably, the N-terminal halves of human (Schall et al., 1990 ; Loetscher et al., pression of FAN or of N-terminal FAN deletion mutants demonstrates that FAN mediates TNF-induced activa-1990) and mouse (Lewis et al., 1991) TNF receptor cytoplasmic domains show in general a lower degree of tion of N-SMase and, therefore, is likely to play an important role in the regulation of major inflammatory cellular homology than the C-terminal halves. However, the binding sites observed within the N-terminal half fall into responses to TNF.
the regions of greater conservation ( Figure 1D ).
Since a peptide scanning library clearly revealed a Results linear protein binding motif precisely corresponding to the functionally mapped NSD, we used a peptide library Identification of a Novel TNF-R55-Associated staggered by only one amino acid each to identify NSDProtein That Binds to the NSD interacting proteins within the cohort of cDNA clones To identify proteins that directly interact with the cytoobtained by the yeast interaction trap system. Individual plasmic domain of TNF-R55, we used the yeast interaccDNAs were in vitro transcribed or translated, and the tion trap system (Gyuris et al., 1993 ). Since we were resulting radiolabeled proteins were individually tested especially interested in proteins that couple TNF-R55 for binding to the staggered peptides. One clone, desigto the N-SMase pathway, we fused a DNA fragment nated 73.31, showed specific binding to this region sigcoding for amino acids 206-345 to the LexA DNA-bindnificantly greater than background binding ( Figure 2 ). ing domain. Using deletion mutants of TNF-R55, we have
We did not observe specific binding of clone 73.31 to previously demonstrated that this region is sufficient to any other peptide outside the NSD throughout the entire generate the N-SMase activating signal (Wiegmann et cytoplasmic region of TNF-R55 (data not shown). . The TNF-R55 bait construct was used to minimally required amino acid content of the binding screen a Jurkat cDNA expression library for interacting motif for this protein could be mapped to amino acids proteins. A cohort of 18 clones was isolated that showed 310-318. Since our novel protein binds to amino acids specific interaction with the cytoplasmic domain of TNFwithin the motif previously demonstrated to be associ-R55 (data not shown). ated with N-SMase activation (Adam et al., 1996) , it was To identify a cDNA clone or clones coding for a protein designated FAN. Sequence analysis of FAN(73.31) reor proteins that mediate the activation of the N-SMase vealed a partial cDNA insert of about 1 kb that by compathway, we took advantage of our previous work, which parison with the EMBL nucleotide sequence database revealed a small region (amino acids 309-319), directly appeared to represent the 3Ј-terminus of a novel gene. adjacent to the death domain, which was necessary and A short 3Ј-terminal stretch of FAN(73.31) was found to be sufficient to activate N-SMase (NSD; Figure 1A ; Adam et identical with randomly sequenced expressed sequence al., 1996). To examine whether this functionally mapped tags, one of which was assigned to human chromosome NSD contains binding sites for possible protein interac-8 (Murakawa et al., 1994) . tion, we generated a cellulose-bound peptide scanning library (Kramer et al., 1994; Weihergrä ber et al., 1996) FAN Is a Ubiquitously Expressed WD-Repeat Protein containing overlapping peptides of the entire cytoFull-length coding sequence for FAN was obtained by plasmic domain of TNF-R55 ( Figure 1B ). Jurkat cells screening human cDNA libraries with the partial cDNA were metabolically labeled, and extracts were assayed fragment of clone FAN(73.31) . Sequence analysis of this for binding. The NSD (amino acids 309-319) strikingly cDNA clone revealed a 2751 bp open reading frame corresponded to the strong binding site (7-fold above beginning with a translational initiation consensus sebackground binding) on peptide 36 containing amino quence (Kozak, 1987) and predicting a polypeptide of acids 307-321 ( Figures 1B and 1C) . Since the neigh-917 amino acids with a M r of 104,312 ( Figure 3A) . The boring peptides, 35 and 37 (amino acids 304-318 and 5Ј-end was confirmed by additionally performed rapid 310-324), were both missing one amino acid at either amplification of cDNA ends-polymerase chain reaction end, peptide 36 was the only one completely containing on human and mouse mRNA. the functionally mapped NSD. In addition, at least five A comparison of the predicted amino acid sequence more distinct regions were found to bind proteins (Figure with the National Biomedical Research Foundation-PIR 1C). A set of three strong protein binding sites (at least databank revealed significant homologies with a number 5-fold above background binding) were found in the of WD-repeat proteins, including the human LIS-1 protein, the Drosophila transcription factor IID-associated C-terminal half of the TNF-R55 cytoplasmic domain on 35 Smethionine-labeled protein extract from Jurkat cells was assayed for binding to the receptor-derived peptide scanning library. Bound radioactivity was visualized by autoradiography and quantified using laser densitometer scanning of the autoradiographs. Regions of increased binding activity (at least 4-fold above background binding) are boxed and marked by Roman numerals. (D) Homology plot of amino acids 202-326 of the human TNF-R55 (Loetscher et al., 1990) and the mouse TNF-R55 (Lewis et al., 1991) . Colons mark identical amino acids; periods mark conservative changes. The binding domains identified in (C) are boxed and marked by corresponding numerals.
protein, and the yeast TUP-1 gene product (reviewed 1990; Loetscher et al., 1990) and is consistent with FAN involvement in TNF-R55 signal transduction. The apparby Neer et al., 1994) . Further analysis showed that the C-terminus of FAN contained five WD-repeats (Figure ent size of the FAN mRNA of 3.8 kb corresponds to the length of the isolated cDNA clones. 3B). None of these WD-repeats had more than four mismatches within its core sequence spanning 29-31 amino acids, consistent with the range of 23-41 amino acids FAN Specifically Interacts with the NSD of TNF-R55 Specific interaction of the entire FAN protein (amino in other members of this class of proteins (Neer et al., 1994) . Interestingly, the growing family of WD-repeat acids 3-917) as well as of the truncated FAN protein (FAN[73.31] , amino acids 703-917) with the NSD of TNFproteins appears to be composed mostly of regulatory proteins, some of them involved in signal transduction R55 was demonstrated in additional yeast interaction trap experiments. Full-length or truncated FAN fused to (Neer et al., 1994) . In addition, the N-terminus of FAN has significant homology to a human protein homologous to the transcriptional activation domain was coexpressed with various TNF-R55 deletion mutants or a panel of yeast CDC4 (Feuchter et al., 1992) , a WD-repeat protein of unknown function. unrelated proteins fused to the LexA DNA-binding domain (Table 1 ). Both full-length and truncated FAN(703-Northern blot analysis revealed that the mRNA encoding FAN is expressed in a wide variety of human tissues 917) strongly interacted with TNF-R55 constructs containing the NSD. As expected, the cytoplasmic domain (data not shown). This expression pattern corresponds to the ubiquitous expression of TNF-R55 (Schall et al.,
of the deletion mutant TNF-R55⌬308-340 lacking the The cDNA of clone 73.31 was in vitro transcribed or translated, and the radiolabeled protein was incubated with a receptor-derived cellulose-bound peptide scanning library. The binding activity resulting from laser densitometer scanning of autoradiographs is shown for peptides containing the indicated amino acids in comparison with a nonspecific protein (clone 39.1) used as a control.
NSD (Adam et al., 1996) failed completely to interact with full-length or truncated FAN. Control baits consisting of either the unrelated protein tyrosine kinase SYK or re- partner. This effect, however, was significantly en- ) are indicated.
hanced in the presence of the TNF-R55⌬345 cyto-(B) Alignment of the five WD-repeats located in the C-terminus of FAN. The WD-consensus sequence according to Neer et al. (1995) plasmic domain fused to the activation domain, confirm- together, the interaction trap assay strongly suggested a highly specific interaction between FAN and TNF-R55, strictly requiring the presence of the NSD. The NSDTaken together, these results confirm the specific interbinding site of FAN is apparently located within the action of FAN and TNF-R55 in intact cells. C-terminal WD-repeat region (703-917).
To demonstrate physical interaction between FAN and TNF-R55 in intact cells, we left COS-1 cells un-FAN Mediates Activation of N-SMase transfected or transfected with the FLAG-tagged fullTo address the role of FAN for the activation of N-SMase, length FAN fusion construct or the vector pFLAG.CMV2.
we investigated the ability of the NSD-derived pepIdentical amounts of cellular lysates were immunopretide containing amino acids 307-321 (D2A) to interfere cipitated using the ␣-TNF-R55 monoclonal antibody with TNF-induced sphingomyelin hydrolysis. Increasing htr-9 or an isotype-matched monoclonal control antiamounts of the peptide D2A or a control peptide conbody against human CD28. The reactivity of htr-9 with taining death domain-derived amino acids (E2A) were simian TNF-R55 was previously confirmed by FACS incubated with membrane fractions of Jurkat cells prior analysis (data not shown). Western blotting with the to TNF treatment. As shown in Figure 5 , N-SMase activa-␣-FLAG antibody MAb5 detected a protein of approxition was effectively inhibited by peptide D2A but not mately 100 kDa, corresponding to the predicted size of by the control peptide. Thus, the NSD-derived peptide the FLAG-FAN fusion protein, only in FLAG-FANspecifically blocked the activation of N-SMase, probably transfected cells immunoprecipitated with the ␣-TNFowing to competitive binding of FAN, which provides R55 antibody htr-9 (Figure 4 ). FLAG-FAN was detected the first means of selective and specific interference neither in immunoprecipitations with the control antiwith N-SMase activation. body, nor in lysates from cells transfected with the vector pFLAG.CMV2 or from untransfected cells (Figure 4) .
To demonstrate directly the involvement of FAN in the Figure 6C ). Similar to the results shown in Figure 6A , expression of FAN(448-917) exhibited a dominant negative effect on TNF-induced N-SMase activation, while complete FAN enhanced TNF-induced N-SMase activation ( Figure 6C ). FAN-induced changes of N-SMase activities were less pronounced when compared with Figure 6A , because transfectants were not enriched by CD4. Taken together, our results clearly show that the interaction of FAN with the NSD is responsible for mediating TNF-induced N-SMase activation, while the A-SMase pathway remains unaffected.
Discussion
During the last few years, the intracellular events by which TNF-R55 transmits signals through the cell membrane into cytoplasm and nucleus after ligand binding have begun to be elucidated. There are two major pathways that have been shown to involve phospholipases: the A-SMase pathway and the N-SMase pathway, both leading to different cellular responses . The structural motifs within the cytoplasmic domain of TNF-R55 initiating these signals have been identified: a C-terminal domain signals the A-SMase pathway , which seems to be identical to the death domain-signaling apoptosis (Brakebusch et al., 1992; Tartaglia et al., 1993b) . Another functional domain, the N-terminal NSD, is responsible for the N-SMase pathway (Adam et al., 1996) . However, direct links between TNF-R55 and N-SMase, which could provide hints on the activation mechanisms, have not been ing WD-repeats are dominant-negative inhibitors of
Structure of FAN
Sequence analysis of the predicted open reading frame encoding FAN revealed its structural homology to the family of WD-repeat proteins (for review, see Neer et al., 1994) . These proteins have in common the presence of at least four WD-repeats. All so far described WDrepeat proteins appear to serve regulatory functions in various cellular processes. Notably, none of them contains an intrinsic enzymatic function. Many WD-repeat proteins are involved in signal transduction, such as the ␤-chains of heterotrimeric G proteins (Watson et al., 1994) , RACK1 (Ron et al., 1994) , the PLA2-activator protein (PLAP; Clark et al., 1991) , the regulatory subunit of phosphatase 2A (Mayer et al., 1991) , or the recently described protein associated with the type II TGF-␤-receptor (Chen et al., 1995) . Some of them consist only of WD-repeats (for example, RACK1; Ron et al., 1994) , others contain N-or C-terminal extensions of various lengths (for example, PLAP; Clark et al., 1991) . The WDrepeat structure seems to be a functional motif that may facilitate defined protein-protein interactions, sometimes leading to multiprotein complexes, as shown for (Figure 7) . the 627 amino acids N-terminal of the WD-repeats does It should be emphasized that FAN is clearly distinct not provide any evidence for potential enzymatic activifrom any other TNF-R55-associated protein so far deties of FAN. The N-terminal extension of FAN shares scribed. Characterizations of TRADD (Hsu et al., 1995) a sequence homology of amino acids 304-575 (53.8% and, in turn, TRADD-associated proteins (Hsu et al., sequence identity) with another human WD-repeat pro1996a; 1996b), have provided a possible link of the death tein of unknown function (Feuchter et al., 1992) , which domain with the activation of PC-PLC, A-SMase, inducsuggests the existence of a family of FAN-related protion of NF-B, and apoptosis. Despite the identification of proteins binding to TNF-R55 outside the death doteins. main, none of these proteins can provide a possible link between the NSD and activation of N-SMase. TRAP1
Biological Implications of FAN-Associated and TRAP2, proteins that possess sequence homology Nonapoptotic Signals to the 90 kDa family of heat-shock proteins, display While a more detailed picture is beginning to emerge binding properties not consistent with binding to the for the signals leading to the A-SMase/apoptotic pathfunctionally defined NSD (Song et al., 1995) . The binding way by identifying the death domain and its major intersite of TNF-R55 for a protein with homology to the yeast action partners (Tartaglia et al., 1993b; Hsu et al., 1995 , equivalent of the p112 subunit of the 26S proteasome 1996a, 1996b), the N-SMase pathway has been investi-(55.11) has been mapped to amino acids 243-308, upstream of the NSD (Boldin et al., 1995) . gated less intensively. We have recently suggested a ␤-mercaptoethanol, and 50 g/ml each of streptomycin and penicilsequential activation of N-SMase, proline-directed prolin. Highly purified recombinant human TNF (3 ϫ 10 7 U/mg) was tein kinases, and PLA2 as an independent signaling casprovided by G. Adolf (Boehringer Research Institute). The ␣-TNFcade . This N-SMase pathway R55 monoclonal antibody htr-9 (Brockhaus et al., 1990) was a gift involves the activation of various important signaling from W. Lesslauer and H. Loetscher, and the ␣-CD28 monoclonal systems. Activation of membrane-bound N-SMase itself antibody was purchased from Dianova. The monoclonal ␣-FLAGantibody (MAb5) was purchased from Kodak International Biotechis a very early step in TNF-R55 signaling, leading to nologies. Peptides were synthesized using an automated syntheproduction of the second messenger molecule ceramide sizer (Abimed) according to the standard Fmoc machine protocols. (Dressler et al., 1992; Wiegmann et al., 1994) . Ceramide
After cleavage of the protection groups, the products were purified production by N-SMase has been shown to lead to a by High Pressure Liquid Chromatography to greater than 95%.
sequential activation of a ceramide-activated kinase, ceramide-activated protein kinase (Liu et al., 1994) , raf-1
Plasmid Construction
kinase (Belka et al., 1995; Yao et al., 1995) , and MAP
The LexA DNA-binding domain fusions were constructed in the vector plex202 (a gift from R. Brent). The cytoplasmic domains of kinases (Vietor et al., 1993) . phorylation (Lin et al., 1993) , which leads to production restricted by MluI/NotI. The generation of the Jurkat cDNA library of arachidonic acid and finally to the secretion of profused to a synthetic activationdomain has been described elsewhere staglandine E 2 and leukotrienes, important mediators of (Stanger et al., 1995) . The plex. Transformation of the yeast strain EG48/JK103 (Gyuris et al., 1993) We have previously shown that the signaling caswith bait constructs and, subsequently, with the library DNA or cades initiated by the death domain do not overlap with selected activation domain fusion constructs, was performed as the N-SMase pathway . Indeed, described (Stanger et al., 1995) . Transformants were grown on Ura 
Protein Binding to a TNF-R55-Derived Cellulose-Bound Peptide Scanning Library Experimental Procedures
The TNF-R55-derived peptide scanning libraries were automatically prepared by spot synthesis (Frank, 1992) using a spot synthesizer Cell Culture and Biological Reagents The human leukemic T cell line Jurkat and COS-1 cells were origi-(Abimed) and the software DIGEN (Jerini Bio Tools), as described in detail elsewhere (Kramer et al., 1994; Reineke et al., 1996) . We nally obtained from the American Type Culture Collection. All cell lines were grown in Click's RPMI culture medium (Biochrom) suppleprepared two different scans covering the entire cytoplasmic domain of TNF-R55: one library containing 15 mer (12 amino acids mented with 10% fetal calf serum, 10 mM glutamine, 0. , 1992) . Thereafter, cells were stimulated with TNF. Ceramide was dium for 4 hr, washed twice in PBS, and lysed in HDP (30 mM HEPES [pH 7.9], 10% glycerol, 7 mM MgCl 2, 10 mM KCl, 1 mM dithiothreitol, quantitated by the diacylglycerol kinase assay as described by Dressler and Kolesnick (1990) . Cells were extracted with chloroform : 0.1% NP40, 10 g/ml of aprotinin and leupeptin) by freezing/thawing. The cell lysate was incubated on peptide filters, prewashed methanol : 1N HCl (100 : 100 : 1, v/v/v), and lipids were dried under N 2. The extracts were incubated with 0.1 N methanolic KOH for 1 twice in methanol and twice in PBS in 1 ϫ blocking reagent (Cambridge Research Biochemicals) and in HDP overnight at 4ЊC with hr at 37ЊC to remove glycerophospholipids. After reextraction, the organic phase was dried under N 2. Ceramide was measured using continuous shaking. After five washes at room temperature in NET (150 mM NaCl, 50 mM Tris [pH 7.5], 5 mM EDTA, 0.05% NP40), the sn-1,2-diacylglycerol (DAG) assay reagents system (Amersham), following the protocol provided by the manufacturer. Ceramide filters were air-dried and autoradiographed. Radiolabeled proteins encoded by the clones derived from the interaction trap screening 1-phosphate levels were determined by two-dimensional laser densitometry of autoradiographs. Ceramide levels were quantified by were generated using the TNT T7-coupled Reticulocyte Lysate System (Promega) and 35 S-methionine (Amersham). Screening of the comparison with a standard curve of ceramide 1-phosphate generated by subjecting 30-500 pmol of ceramide (ceramide type III, peptide libraries with the in vitro translated proteins was performed as described above.
Sigma) to the DAG kinase reaction.
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